SEC 13F Intelligence

Davenport & Co LLC / ABT

Davenport & Co LLC’s Abbott Laboratories Position

Does Davenport & Co LLC own Abbott Laboratories (ABT)? Yes — 950.1K shares worth $97M (+0.53% of its 13F portfolio) as of Q1 2026, up from 941.5K shares the prior filed quarter.

Position Value
$97M
Q1 2026
Shares
950.1K
% of Portfolio
+0.53%
Quarters Held
30
currently held

Position History ABT

Reported value by quarter
Q4 ’18: $8MQ4 ’18Q1 ’19: $9MQ2 ’19: $9MQ3 ’19: $9MQ4 ’19: $9MQ4 ’19Q1 ’20: $46MQ2 ’20: $54MQ3 ’20: $64MQ4 ’20: $66MQ4 ’20Q1 ’21: $72MQ2 ’21: $74MQ3 ’21: $84MQ4 ’21: $99MQ4 ’21Q1 ’22: $80MQ2 ’22: $73MQ3 ’22: $64MQ4 ’22: $89MQ4 ’22Q1 ’23: $81MQ2 ’23: $86MQ3 ’23: $93MQ4 ’23: $106MQ4 ’23Q1 ’24: $110MQ2 ’24: $97MQ3 ’24: $106MQ4 ’24: $106MQ4 ’24Q1 ’25: $126MQ2 ’25: $130MQ3 ’25: $127MQ4 ’25: $118MQ4 ’25Q1 ’26: $97Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 2026950.1K$97M+0.53%
Q4 2025941.5K$118M+0.63%
Q3 2025949.8K$127M+0.68%
Q2 2025961.1K$130M+0.71%
Q1 2025953.4K$126M+0.73%
Q4 2024936.8K$106M+0.60%
Q3 2024935.6K$106M+0.60%
Q2 2024935.2K$97M+0.59%
Q1 2024966.5K$110M+0.67%
Q4 2023965.5K$106M+0.72%
Q3 2023955.6K$93M+0.70%
Q2 2023792.7K$86M+0.63%
Q1 2023808.4K$81M+0.64%
Q4 2022813.1K$89M+0.73%
Q3 2022661.8K$64M+0.56%
Q2 2022673.9K$73M+0.60%
Q1 2022678.1K$80M+0.55%
Q4 2021700.9K$99M+0.65%
Q3 2021713.2K$84M+0.60%
Q2 2021635.2K$74M+0.57%
Q1 2021604.4K$72M+0.68%
Q4 2020606.8K$66M+0.65%
Q3 2020587.3K$64M+0.71%
Q2 2020589.4K$54M+0.66%
Q1 2020581.5K$46M+0.66%
Q4 2019107.6K$9M+0.10%
Q3 2019105.6K$9M+0.11%
Q2 2019104.6K$9M+0.10%
Q1 2019117.1K$9M+0.12%
Q4 2018116.4K$8M+0.12%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Davenport & Co LLC’s full portfolio or all institutional holders of ABT.